Abstract: The present invention provides for systems and methods for inhaled CO therapy to prevent, attenuate, or delay processes that accelerate the loss of organ or tissue function, thereby increasing the lifespan of transplanted organs or tissues, or slowing the decline of native organs or tissues, or delaying the need for replacement of diseased native organs with organ transplants. Such biological processes that are prevented, attenuated, or delayed include chronic persistent inflammation, fibrosis, scarring, as well as immunologic or autoimmune attack.
Type:
Grant
Filed:
September 12, 2017
Date of Patent:
July 9, 2019
Assignee:
PROTERRIS, INC.
Inventors:
Jeffrey D. Wager, Joseph Wager, Alex Stenzler, David Pinsky, Augustine Choi
Abstract: The present invention provides for systems and methods for inhaled CO therapy to prevent, attenuate, or delay processes that accelerate the loss of organ or tissue function, thereby increasing the lifespan of transplanted organs or tissues, or slowing the decline of native organs or tissues, or delaying the need for replacement of diseased native organs with organ transplants. Such biological processes that are prevented, attenuated, or delayed include chronic persistent inflammation, fibrosis, scarring, as well as immunologic or autoimmune attack.
Type:
Grant
Filed:
April 15, 2015
Date of Patent:
October 17, 2017
Assignee:
PROTERRIS, INC.
Inventors:
Jeffrey D. Wager, Joseph Wager, Alex Stenzler, David Pinsky, Augustine Choi